Replies to post #89555 on Avid Bioservices Inc (CDMO)

[exwannabe]

The bavi trial has the RR as the surrogate endpoint and survival as the clinical benefit endpoint. Here's an example.

The issue though is that there is certainly NOT substantial evidence of an improved RR from this trial. A P value of .3 or such just does not cut it.